IP Library Granted Patent US 7,122,682
Granted Patent B2
US 7,122,682 · App. 10/486,342 · Granted Oct 17, 2006

Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues

Assignee: UCB, S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,122,682
App. No.
10/486,342
Granted
Oct 17, 2006
Kind
B2
Abstract

The present invention relates to an improved process for the preparation of (S)-(−)-α-ethyl-2-oxo-1-pyrrolidine acetamide and analogues thereof. The invention also relates to compounds of the general formula (6) wherein R 1 is methyl or ethyl; and R 2 is C?2#191–C?4#191 alkyl, C?2#191–C?4#191 alkenyl or C?2#191–C?4#191 alkynyl, optionally substituted by one or more halogen, and their preparation processes

Claims (42)

1. A process for the manufacture of a compound of formula (22′)

wherein R 2′ is hydrogen, C 1 –C 4 alkyl, C 2 –C 4 alkenyl or C 2 –C 4 alkynyl, optionally substituted by one or more halogen, said process comprising the ammonolysis of the corresponding compound of formula (6′)

wherein R 1′ is C 1 –C 6 alkyl and R 2′ is hydrogen, C 1 –C 4 alkyl, C 2 –C 4 alkenyl or C 2 –C 4 alkynyl, optionally substituted by one or more halogen, in the presence of water.

2. The process according to claim 1 , wherein said ammonolysis is performed in a mixture of water and an alcohol.

3. The process according claim 1 , wherein said ammonolysis is performed in a 30–80% (w/w) NH 3 solution in water.

4. The process according to claim 1 , wherein said ammonolysis is performed at 0 to 25° C.

5. The process according to claim 1 , wherein the molar ratio of NH 3 to the compound of formula (6′) is at least 4.

6. The process according to claim 1 , wherein a compound of formula (6′) is used wherein R 1′ is methyl and R 2′ is hydrogen.

7. The process according to claim 1 , wherein a compound of formula (6′) is used wherein R 1′ is ethyl and R 2′ is hydrogen.

8. The process according to claim 1 , wherein a compound of formula (6′) is used wherein the R 2′ substituent is present at position 4 on the ring structure, according to the following general formula (7′)

9. The process according to claim 1 , wherein a compound of formula (6′) or (7′) is used wherein R 2′ is selected from the group of propyl, 2,2-difluorovinyl, 2-fluoro-2-methylpropyl, 2,2-difluoropropyl, cyclopropylmethyl and 2,2,2-trifluoroethyl.

10. The process according to claim 1 , wherein compound (6′) is an S isomer according to the following formula (8′)

11. The process according to claim 1 , wherein compound (6′) is obtained by a process comprising following steps:

(a) reaction of a compound of formula (9)

 with an alcohol of formula R 1′ OH wherein R 1′ is as noted in claim 1 ,

(b) reaction of the corresponding compound of formula (10′) thus obtained

 with a R 2′ -substituted-ethyl-4-bromobutyrate wherein R 2′ is as noted in claim 1 ,

(c) cyclisation of the corresponding compound of formula (11′) thus obtained

 in the presence of a catalyst, and

(d) isolation of the resulting compound.

12. The process according to claim 1 , wherein compound (6′) is obtained by a process comprising a step of cyclisation of a compound of formula (11′)

wherein R 1′ and R 2′ are as noted in claim 1 .

13. The process according to claim 1 , wherein compound (6′) is obtained by a process comprising following steps:

(a) reaction of an α-ketocarboxylic acid derivative of formula (12′)

 wherein R 1′ is as noted in claim 1 , with a pyrrolidinone of formula (13′)

 wherein R 2′ is as noted in claim 1 ,

(b) reaction of the corresponding compound of formula (14′) thus obtained

 with hydrogen in the presence of an asymmetric hydrogenation catalyst, and

(c) isolation of the resulting compound.

14. The process according to claim 1 , wherein compound (6′) is obtained by a process comprising following steps:

(a) reaction of a compound of formula (15′)

 wherein R 1′ is as noted in claim 1 and X is Cl, Br, I, alkylsulphonate or sulfate; with a pyrrolidone of formula (13′)

 wherein R 2′ is as in claim 1 ,

(b) reaction of the corresponding compound of formula (16′) thus obtained

 with ethyl-X, wherein X is Cl, Br, I, alkylsulphonate or sulfate in the presence of an asymmetric alkylation catalyst or additive,

(c) isolation of the resulting compound.

15. The process according to claim 1 , wherein compound (6′) is obtained by a process comprising following steps:

(a) reaction of a compound of general formula (20′)

 wherein R 1′ is as noted in claim 1 , with a pyrrolidone of general formula (13′)

 wherein R 2′ is defined as in claim 1 ,

(b) separation of the corresponding compound of formula (21′) thus obtained, and

(c) isolation of the resulting compound of formula (6′).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2008
From: UCB, S.A.
To: UCB PHARMA, S.A.
Reel/Frame 021773/0126 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2004
From: ATES, CELAL; SURTEES, JOHN; BURTEAU, ANNE-CATHERINE; MARMON, VOILETA; CAVOY, EMILE
To: UCB, S.A.
Reel/Frame 015032/0194 →
Priority Claims (1)
EP 01119396 · Aug 10, 2001 · regional
Continuity (1)
Related Publication 20040204476A1 · Oct 14, 2004